Research at Oslo University Hospital

cOAlition S is monitoring developments in the Open Science landscape and is seeking feedback from the research community about their experiences when publishing according to the principles of Plan S.

The survey seeks to gather specific data from the research community about their publishing practices, experiences and impact on career progression.

Professor Håvard E. Danielsen is this year’s recipient of the King Olav V's Cancer Research Prize.

He has been awarded the prize for having developed methods using artificial intelligence (AI) that can give cancer patients a more precise prognosis and counteract overtreatment.

His Majesty the King was responsible for the solemn presentation of the award during a ceremony held in the university’s auditorium in Oslo on May 9th 2022.

The precision cancer medicine ecosystem established in Norway and the ongoing implementation in the health care system are unique in an international context. The description of the entire ecosystem was published in Nature Medicine on May 5th.
“These initiatives represent a triple-win effect,” says first author Kjetil Taskén, Head and Director of Institute of Cancer Research at Oslo University Hospital and Professor at University of Oslo. “The patients gain access to modern treatments; the researchers can investigate the effect of different medicines on new indications; and the industry can expand the application of their drugs.”

The epilepsy research group ERGO at the Department of Neurology, with authors Line Bedos Ulvin, Kjell Heuser and Prof. Erik Taubøll, has participated in a 3-national study to improve the prognostication of long-term survival after status epilepticus.

Early prediction of long-term mortality of status epilepticus is important given the high mortality in the years after diagnosis.

Professor Bente Halvorsen from the Research Institute of Internal Medicine has received The Nikkilä Memorial Lecture Award for 2022. This is a prestigious European award within atherosclerosis research organized by Scandinavian Society of Atherosclerosis Research (SSAR).  
Halvorsen received the award due to her world leading translation research and her scientific contribution in field of cardiovascular diseases with the several highly rated publications where underlying mechanisms for diseases development are identified.

In their largest single call ever, Norway's leading cancer researchers can now compete for a total of NOK 186 million from the Norwegian Cancer Society. While there previously were three annual announcements, everything is now gathered in the same call, called "Research Projects", meaning it is now sufficient for the researchers to submit one application. Then, international, independent peers assess the quality of the project and where it belongs topically.

Deadline for applications is May 31st.

NOK 130 million has been set aside for free research projects, NOK 28 million for breast cancer research and NOK 20 million for research on metastatic cancer. In addition, they are earmarking NOK 8 million for a high-quality project from an applicant community outside the three largest cities.

The Norwegian Cancer Symposium 2022 on the subject "Sustainable cancer care using molecular tests - from a prostate cancer perspective" will be held Sep 14-15 2022. The 2-day symposium brings together top-ranking researchers, clinicians, industry and policymakers, aiming to strengthen collaboration and overcome hurdles for implementing molecular tests in precision medicine.
Abstract deadline: June 1st 2022
Registration deadline: June 15th 2022

The American Association for Cancer Research (AACR) recently announced its newly elected class of Fellows of the AACR Academy. Among the 33 members of the 2022 class is Anne-Lise Børresen-Dale, Professor Emerita at University of Oslo and previous head of Department of Cancer Genetics, Oslo University Hospital Radiumhospitalet.

The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Only individuals whose work has had a significant and enduring impact on cancer research are considered for election and induction into the AACR Academy.

A 3D-superresolution microscopy image (3D-SIM) of the cell’s sensory organelle, the primary cilium, obtained by the Centrosome & Cell Division Cycle project group was selected for the cover of the latest issue of Bio-protocol.

In this issue, Frikstad and colleagues report a detailed protocol for the analysis of centrosomes by 3D-SIM. The method was applied in two earlier reported studies on functional analysis of disease causing mutations in centrosomal proteins published in the prestigious journals Cell Reports and eLife.